Objectives To assess disease trends, testing practices, community surveillance, case-fatality
and excess deaths in children as compared with adults during the first pandemic peak in …

2019 (COVID-19) pandemic was the observation that children are much less likely to
experience severe illness than adults. 1 This remains true, but has created a perception that …

Background Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-
C) has been described as a novel and often severe presentation of SARS-CoV-2 infection in …

Background Most pediatric coronavirus disease 2019 (COVID-19) is mild. We assessed
nationally severe COVID-19, including pediatric inflammatory multisystem syndrome (PIMS) …

We urgently need guidelines for managing COVID‐19 in children with comorbidities - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Background Previous studies assessing the prevalence of COVID-19 sequelae in adults and
children were performed in the absence of an agreed definition. We investigated prevalence …

Background: Many aspects of SARS-CoV-2 infection in children and adolescents remain
unclear and optimal treatment is debated. The objective of our study was to investigate …

Background: There are limited pediatric data regarding severe COVID-19 disease. Our study
aims to describe the epidemiology and identify risk factors for severe COVID-19 disease in …

Background The coronavirus disease 2019 (COVID‐19) pandemic continues to cause
global havoc posing uncertainty to educational institutions worldwide. Understanding the …

Multisystem inflammatory syndrome in children (MIS-C) is a novel disease that is associated
with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 1 Until now, only …